Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
Zelenirstat cancer pill made in Alberta shows promising early results

Zelenirstat cancer pill made in Alberta shows promising early results

Global News
Wednesday, February 12, 2025 02:35:57 PM UTC

Zelenirstat, a cancer-fighting pill made in Alberta, may have the power to save lives — but millions more in clinical trial funding and donations are needed to make it a reality.

Imagine being able to treat cancer by taking one pill a day. Right now, a research team at the University of Alberta is trialing just that.

Professor Luc Berthiaume has been working to find a cure for cancer for decades.

“I came here to find a new way to kill cancer cells with minimized side effects,” Berthiaume said of joining the U of A.

Years ago, he had an idea to treat cancer in an unconventional way. His idea even got him laughed at while attending graduate school at the Université de Sherbrooke in Quebec.

But now, clinical trials are proving his theory by attacking mitochondria in cells.

“It inhibits the cell signalling inside cells that tells cells to grow aberrantly without stopping. They grow, grow, grow,” Berthiaume explained.

“In addition to inhibiting the growth, our drug suffocates the cells and starves them  and this effect is more preponderant in the cancer cells, rather than in normal cells.”

His novel drug shuts down the cell’s metabolism, preventing them from converting oxygen into energy.

Read full story on Global News
Share this story on:-
More Related News
Conservation officers no longer ‘actively’ looking for grizzly bears in Bella Coola attack

Officers had recently captured four grizzly bears, but forensic results came back to confirm that none of the bears, an adult female and three young, were linked to the attack.

‘Patients get relief’: Researchers recommending nerve blockers to treat migraines

The research recommends occipital nerve blocks should be offered in emergency rooms to treat acute migraine attacks. 

U.S. advisory panel rolls back universal hepatitis B vaccine recommendation

A federal vaccine advisory committee voted on Friday to end the longstanding recommendation that all U.S. babies get the hepatitis B vaccine on the day they’re born.

Alberta mother prepares to welcome ‘miracle’ quadruplets

Darlene Hensch, who once struggled with unexplained infertility, is now expecting quadruplets and preparing for a high-risk delivery and life-changing journey.

Wegovy won’t be in Canadian public drug plans as Novo Nordisk refuses talks

Negotiations that could have led to coverage for weight-loss drug Wegovy under Canadian public health plans are not moving forward.

A ring with an extra carrot ends decades-long mystery for Alberta couple

They've been married for 55 years, but for most of that time, something has been missing from Janet and Robert Cockwill's life, until their grandson made a remarkable discovery.

Liberals are being ‘dishonest’ about future of pharmacare, NDP says

NDP interim leader Don Davies said the government's response to a commissioned report on the program was 'shockingly dismissive,' and the health minister has not committed to act.

Ontario government routinely ignoring environmental consultations, AG finds

The Ford government is routinely making decisions before environmental consultations have concluded and under-resourcing public education about those consultations, the AG found.

Vacancies for nurses, support workers tripled since 2016, StatCan finds

From 2016 to 2024, the vacancy rate for health-related occupations nearly tripled, increasing from 2.1 per cent to 5.8 per cent, the report said.

Alberta’s Smith vows to keep up fight against Ottawa despite pipeline pact

The milestone deal with Ottawa signed earlier this week clears regulatory hurdles for a potential pipeline from Alberta to the West Coast. 

‘Frustrating’: Veterinarians urge regulatory changes as medicine shortages mount

Canadian veterinarians are sounding the alarm about their loss of access to about 40 per cent of medications they once were able to use and they are blaming Health Canada.

© 2008 - 2025 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us